Janus hydrogel with lasting wet tissue adhesion and abdominal adhesion resistance

By introducing a combined structure of an adhesive layer and an anti-adhesive layer into an adhesion hydrogel, using specific materials and crosslinking reactions, the existing hydrogels are solved inadequate adhesion ability and poor biocompatibility on wet tissues. The problem of this problem has achieved the effect of long-lasting adhesion and anti-peritoneal adhesion, and is suitable for biomedical materials.

CN118955951APending Publication Date: 2024-11-15NINGBO MEDICAL CENT LIHUILI HOSPITACL
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202411054198.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-02
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

The existing adhesion hydrogels have limited adhesion ability on wet tissue and poor biocompatibility, which leads to poor long-lasting wet tissue adhesion and anti-peritoneal adhesion in clinical applications.

Method used

Janus hydrogel composed of adhesive layer AL and anti-adhesion layer AAL was prepared by p(APMA-co-THMA), methacrylic anhydride gelatin (GelMa) and acrylic acid (AAc) and other materials, using non-co-co- The covalent bond between the valence and NHS groups forms a firm adhesion, and the anti-adhesion layer uses the hydrophilicity of the zwitterionic ions to achieve anti-bioadhesion.

Benefits of technology

It achieves a long-lasting and strong adhesion on wet tissues, and has excellent anti-peritoneal adhesion effect and appropriate biocompatibility, which is suitable for the field of biomedical materials.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118955951A_ABST
    Figure CN118955951A_ABST
Patent Text Reader

Abstract

The invention discloses Janus hydrogel with lasting wet tissue adhesion and abdominal adhesion resistance. The Janus hydrogel consists of an adhesion layer AL and an anti-adhesion layer AAL, the preparation method is simple, efficient and low in cost. For the adhesion layer AL, firm adhesion is formed on a moist tissue through the synergistic effect of covalent bonds of non-covalent and NHS groups, and the tridentate hydrogen bond of APMA-co-THMA provides a lasting and strong adhesion effect for AL. And the anti-adhesion layer ALL utilizes the hydrophilicity of zwitterions so as to realize the anti-biological adhesion characteristic. Therefore, the hydrogel patch prepared by the invention has proper biocompatibility, and also has excellent adhesion and anti-adhesion effects. Wide application prospects are realized in the field of biomedical materials.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of polymer hydrogels, in particular to a Janus hydrogel with the functions of lasting wet tissue adhesion and anti-abdominal adhesion. Background Art

[0002] Hydrogels are widely used in the field of tissue engineering because of their good three-dimensional network structure and high water content. Among them, adhesive hydrogels have developed particularly rapidly and have been applied in many medical fields, such as wound suturing and drug release. Unfortunately, however, the adhesive hydrogels (such as cyanoacrylates and fibrin glues) currently used in clinical practice have limited adhesion to wet tissues, which greatly hinders the application and development of hydrogels. In addition, the poor biocompatibility of cyanoacrylate-based adhesives also greatly limits their development. The hydration layer on the surface of wet tissue is the main reason for the limited adhesion, which hinders the interaction between the hydrogel and the wet tissue interface. Hydrogels with good wet tissue adhesion are particularly important in many aspects, such as applications in heavy bleeding, gastric perforation and pneumothorax. Compared with U-shaped staples and surgical sutures, adhesive hydrogels have better biocompatibility and ease of operation.

[0003] Inspired by natural organisms, scientists have discovered that the mechanism of mussel underwater adhesion is produced by mussel foot proteins (Mfps). 3,4-dihydroxyphenylalanine (DOPA) in Mfps plays an important role in wet tissue adhesion, including DOPA-mediated hydrophobic effects and bidentate hydrogen bonds. In fact, the catechol structure in DOPA is easily oxidized, but the reducing groups in Mfps solve this problem. Unfortunately, the catechol group will cause the adhesion to decrease due to oxidation, so the sustained adhesion performance needs to be verified. Therefore, mimicking the adhesion mechanism of mussels requires strict control of the redox environment, but this is usually complicated and time-consuming.

[0004] In addition, preventing postoperative surgical adhesions is one of the major clinical challenges. Among patients undergoing abdominal surgery, 80% develop postoperative abdominal adhesions. Abdominal adhesions can lead to serious complications, such as intestinal obstruction. Therefore, there is an urgent need to develop a double-sided tissue patch with asymmetric adhesion effects, which has both long-lasting and high-strength adhesion properties and the ability to resist abdominal adhesions. Summary of the invention

[0005] The purpose of the present invention is to solve the problems of poor wet tissue adhesion and postoperative adhesion in existing medical materials, and to provide a Janus hydrogel with long-lasting wet tissue adhesion and anti-abdominal adhesion.

[0006] The technical solution of the present invention is as follows: a Janus hydrogel with durable wet tissue adhesion and resistance to peritoneal adhesion, composed of an adhesion layer AL and an anti-adhesion layer AAL;

[0007] The adhesive layer AL is mainly obtained by polymerization of p(APMA-co-THMA), methacrylic anhydride gelatin (GelMa), acrylic acid (AAc) and acrylic acid N-hydroxysuccinimide ester (AAc-NHS); the p(APMA-co-THMA) is obtained by polymerization of N-[tris(hydroxymethyl)methyl]acrylamide (THMA) and N-(3-aminopropyl)methacrylamide hydrochloride (APMA);

[0008] The anti-adhesion layer AAL is obtained by cross-linking reaction after the single-side of the adhesion layer AL is immersed in AAL prefabricated liquid; the AAL prefabricated liquid includes [2-(methacryloyloxy)ethyl]dimethyl-(3-sulfonic acid propyl)ammonium hydroxide (SBMA), methacrylic anhydride gelatin (GelMa) and N,N'-methylenebisacrylamide (MBAA).

[0009] Preferably, the Janus hydrogel having long-lasting wet tissue adhesion and anti-peritoneal adhesion comprises the following preparation steps:

[0010] 1) Grafting methacrylic anhydride onto gelatin to obtain methacrylic anhydride gelatin (GelMa), polymerizing N-[tris(hydroxymethyl)methyl]acrylamide (THMA) and N-(3-aminopropyl)methacrylamide hydrochloride (APMA) to obtain p(APMA-co-THMA);

[0011] 2) preparing an AL pre-liquid for the adhesion layer: adding p(APMA-co-THMA), methacrylic anhydride gelatin (GelMa) and a photoinitiator LAP to water; after fully dissolving and stirring at 40° C., adding acrylic acid (AAc) and acrylic acid N-hydroxysuccinimide ester (AAc-NHS) and stirring evenly to obtain an AL pre-liquid;

[0012] 3) deoxygenating the AL prefabricated liquid and injecting it into the mold to crosslink under ultraviolet light to obtain the adhesive layer AL; then washing and drying;

[0013] 4) preparing an anti-adhesion layer AAL pre-made solution: adding [2-(methacryloyloxy)ethyl]dimethyl-(3-sulfonatepropyl)ammonium hydroxide (SBMA), methacrylic anhydride gelatin (GelMa), N,N'-methylenebisacrylamide (MBAA) and ammonium persulfate (APS) into water and mixing them evenly to obtain an AAL pre-made solution;

[0014] 5) Soaking one side of the dried adhesive layer AL in the AAL prefabricated liquid for a period of time and then taking it out, and then thermally cross-linking it at 60° C. to obtain the Janus hydrogel.

[0015] Optimally, the mass percentage concentration of each component in the AL prefabricated solution is: AAc 30%; AAc-NHS 2%; p(APMA-co-THMA) 2%; GelMa 0.2%; photoinitiator LAP 0.2%.

[0016] Optimally, the concentrations of the components of the AAL preformed solution are: SBMA 20%; MBAA 0.6%; GelMa 2%; and thermal initiator ammonium persulfate 1%.

[0017] Preferably, in step 3), deoxygenation is performed by filling with nitrogen for 10-20 minutes.

[0018] Preferably, in step 3), the wavelength of the ultraviolet light is 365 nm, and the irradiation time is 20-30 min.

[0019] The beneficial effects of the present invention are as follows: the preparation method of the present invention is simple, efficient and low in cost. For the adhesion layer AL, it forms a firm adhesion on the wet tissue through the synergistic effect of the covalent bonds of the non-covalent and NHS groups, and the "tridentate hydrogen bond" of APMA-co-THMA provides AL with a lasting and strong adhesion effect. The anti-adhesion layer ALL utilizes the hydrophilicity of zwitterions to achieve anti-biological adhesion properties. Therefore, the hydrogel patch prepared by the present invention has appropriate biocompatibility and excellent adhesion and anti-adhesion effects. It has broad application prospects in the field of biomedical materials. Considering the dynamic humid environment in the abdominal cavity, it is very important to remove the surface water and layer of tissue adhesion for wet adhesion. For this reason, the present invention performs a drying treatment on the adhesion layer AL so that the adhesion layer AL has the ability to absorb water quickly. The strong adhesion between the adhesion layer AL and the tissue mainly depends on the hydrogen bonding effect from the carboxyl and hydroxyl groups and the covalent bonds formed by the NHS group and the tissue. SBMA can effectively resist protein and cell adhesion because its zwitterions have good hydrophilic properties. BRIEF DESCRIPTION OF THE DRAWINGS

[0020] Figure 1 Scanning electron microscope images of the Janus transition layer prepared in Example 3 and the hydrogels prepared from AL and AAL alone.

[0021] Figure 2 is the dN of the adhesive layer AL prepared in Example 1-6 after drying X P Y Swelling curve diagram.

[0022] Figure 3The equilibrium swelling ratio of the hydrogel after drying of the adhesion layer AL prepared in Example 3 and the JGP prepared in Example 3.

[0023] Figure 4 is the dN of the adhesive layer AL of Examples 1-6 after drying X P Y Maximum adhesion force diagram.

[0024] Figure 5 This is a comparison chart of the maximum wet tissue adhesion of undried N2P2 and d-N2P2 prepared in Example 3.

[0025] Figure 6 The CCK-8 data graph of the undried N2P2 prepared in Example 3 and the JGP prepared in Example 2.

[0026] Figure 7 It is the hemolysis experiment data chart of the undried N2P2 prepared in Example 3 and the JGP prepared in Example 2.

[0027] Figure 8 This is the anti-peritoneal adhesion effect of the JGP prepared in Example 3. DETAILED DESCRIPTION

[0028] The present invention is further described in detail below with specific examples, but the present invention is not limited to the following specific examples.

[0029] Follow the steps below to prepare Janus hydrogel:

[0030] 1) Dissolve 10g gelatin in 100ml phosphate buffer (PBS), and after it is completely dissolved at 60°C, slowly and evenly add 6mL methacrylic anhydride to the solution. Then adjust the temperature to 50°C and react for 1 hour. After the reaction is completed, dialyze in deionized water (molecular weight cutoff is 8KD-14KD) for at least three days, change the water at least 3 times a day, and freeze-dry after dialysis to obtain methacrylic anhydride gelatin (GelMa);

[0031] 2) In a nitrogen environment, 728 mg of N-[tris(hydroxymethyl)methyl]acrylamide (THMA) and 185 mg of N-(3-aminopropyl)methacrylamide hydrochloride (APMA) were dissolved in 6 mL of deionized water. Then 23 mg of ammonium persulfate (APS) was added to initiate polymerization at 60°C for 1 hour, and the temperature was adjusted to 70°C. After 7 hours of reaction, the reaction was terminated. After the reaction was completed, it was dialyzed in deionized water (molecular weight cutoff of 3500D-7000D) for at least three days, and the water was changed at least 3 times a day. After dialysis, p(APMA-co-THMA) was obtained by freeze drying.

[0032] 3) Preparation of adhesive layer AL prefabricated solution: add 0.1-0.5g p(APMA-co-THMA), 0.02g GelMa and 0.02g photoinitiator LAP to 10g water; after fully dissolving and stirring at 40°C, add 3g acrylic acid (AAc) and 0-0.2g acrylic acid N-hydroxysuccinimide ester (AAc-NHS) and stir evenly to obtain AL prefabricated solution. For the convenience of the subsequent performance comparison experiment description, when AAc-NHS accounts for X% of the water mass and p(APMA-co-THMA) accounts for Y% of the water mass in the AL prefabricated solution, the prepared adhesive layer AL is named N X P Y .

[0033] 4) Fill the AL preformed liquid with nitrogen for 10 minutes to remove oxygen.

[0034] 5) In a nitrogen atmosphere, the AL prefabricated liquid is injected into a glass plate mold and cross-linked for 30 minutes under ultraviolet light with a wavelength of 365 nm to form a gel. The shape of the mold cavity can be a sheet with a certain thickness.

[0035] 6) The gelled adhesive layer AL is then immersed in deionized water to remove monomer molecules with biological toxicity, and then dried at 60°C.

[0036] 7) Preparation of the anti-adhesion layer AAL pre-solution: First, 2 g SBMA, 0.2 g GelMa, 0.06 g MBAA and 0.1 g ammonium persulfate (APS) were added to 10 g water, and then the mixed solution was stirred to obtain the AAL pre-solution.

[0037] 8) The adhesive layer AL dried in step 6) is placed in a mold and immersed on one side (e.g., the lower surface) in the AAL prefabricated liquid prepared in step 7) for 30 minutes, then taken out and placed in a mold for thermal crosslinking at 60° C. for 60 minutes to obtain a Janus hydrogel.

[0038] 9) For microstructure comparison, an anti-adhesion layer AAL single layer adhesive was synthesized separately, that is, the AAL preformed liquid was directly placed into a mold and thermally cross-linked at 60° C. for 60 min to obtain AAL.

[0039] In the embodiment, the Janus hydrogel refers to the hydrogel composed of two layers, the adhesion layer AL and the anti-adhesion layer AAL, prepared in step 8). X P Y Represents the undried adhesive layer AL prepared in step 5); dN X P Y It represents the dried adhesive layer AL prepared in step 6) above; JGP specifically refers to the Janus glue formed by soaking N2P2 on one side.

[0040] According to the different proportions of the components in step 3), specific examples 1-6 are obtained as shown in Table 1 below.

[0041] Table 1 Step 3) Ingredients

[0042]

[0043] The Janus hydrogels prepared in Examples 1-6 were subjected to performance tests. Since N2P2 has the best adhesion effect, for the convenience of description, the Janus gel prepared from N2P2 is referred to as JGP. The test includes the following aspects:

[0044] 1) Microstructural characteristics: To evaluate the microstructure of PSBMA hydrogel (AAL), Janus hydrogel transition layer and AL, the freshly prepared PSBMA gel, JGP and AL were placed in a -80 °C freezer for 8 h and then freeze-dried to obtain dry samples. The JGP microstructure was observed by scanning electron microscopy (SEM, TM-3000, HITACHI).

[0045] 2) Swelling test: To evaluate the swelling behavior of AL and JGP of different components, a patch of a certain size was immersed in phosphate buffered saline (PBS; pH = 7.4) at 37°C and shaken at 60 rpm. At each specific time point, the patch was taken out and the surface moisture was wiped off. The patch was then weighed. The swelling rate was calculated as follows:

[0046]

[0047] Where W0 is the weight of the newly prepared hydrogel patch on day 0, W t is the weight of the hydrogel patch after swelling on day t. All tests in each group were repeated 4 times.

[0048] 3) Adhesion test: To determine the adhesion performance of AL, a lap shear test was performed. The pigskin was cut into 25mm×75mm pieces, and AL was bonded to two pieces of pigskin with an overlap size of 25mm×30mm. A soft material mechanical testing machine (INSTRON) equipped with a 1000N mechanical sensor was used, and the two pieces of pigskin were clamped at both ends of the fixture of the testing machine at a constant displacement rate of 20mm / min. The lap shear strength calculation formula is as follows:

[0049]

[0050] Among them, F Max It is the maximum force during lap shear, w and l are the width and length of AL, which are fixed.

[0051] For the wet tissue adhesion performance of AL, the surfaces of two pieces of pigskin were wetted with a certain amount of liquid, and then AL was adhered to the two pieces of pigskin. The two pieces of pigskin were clamped at both ends of the fixture of the testing machine at a constant displacement rate of 20 mm / min. The lap shear strength calculation formula is as described above.

[0052] 4) Biocompatibility evaluation: Before the following series of biocompatibility tests, JGP and N2P2 were sterilized by ultraviolet irradiation before use. In vitro experiments were CCK-8 assay and hemolysis test. In order to evaluate the in vitro cell compatibility of JGP and N2P2, JGP and N2P2 were placed in culture medium and soaked at 37°C for 24 hours to prepare JGP culture medium and N2P2 culture medium. L929 cells were treated with JGP culture medium, N2P2 culture medium and original culture medium and incubated with cells.

[0053] For CCK-8 assay, L929 cells were incubated in a CO2 incubator at 37°C for 1, 2, or 3 days. Cell viability was analyzed using a microplate reader at fixed time points over the 3 days.

[0054] For the hemolysis experiment, 100 mg of JGP and N2P2 were placed in 1 mL of PBS (10×) at 37°C in advance, and the hydrogel extract was prepared after 24 hours. 1 mL of rat blood was collected in an EDTA anticoagulant tube, centrifuged at 2000 rpm and 4°C for 10 minutes in a centrifuge, and the supernatant was discarded. Washed 4 times with 0.9% saline, and a 2% red blood cell suspension was prepared with PBS. The red blood cell suspension and the extracts of JGP and N2P2 were mixed in a ratio of 9:1. PBS was used as the negative control group, and 1% Triton X-100 was used as the positive control group. Then it was placed at a constant temperature of 37°C and incubated for 2 hours. After the incubation was completed, it was centrifuged at 2000 rpm and 4°C for 10 minutes, and the supernatant (100uL) of the control group and the experimental group was taken in a 96-well plate, and the absorbance (OD) of each group at 541nm was measured by an enzyme marker. The hemolysis rate was calculated according to the following formula:

[0055] Hemolysis(%)=(ODSa-ODNe) / (ODPo-ODNe)

[0056] Among them, ODSa is the OD value of JGP and N2P2 groups, ODNe is the OD value of negative control group, and ODPo is the OD value of positive control group.

[0057] 5) Rat cecal adhesion model: In order to evaluate the anti-adhesion effect of JGP in the abdominal cavity, a rat cecal adhesion model was used. SD rats (male, 8 weeks, 220g-250g) were anesthetized by intraperitoneal injection of sodium pentobarbital. The skin was incised in the left lower abdomen, the cecum was gently exposed, and then sterile gauze was repeatedly rubbed on the cecum until obvious bleeding spots appeared on the surface of the cecum. Then JGP was attached to the damaged cecum, and the control group was not treated. Penicillin was given after surgery to prevent postoperative infection. The rats were killed 2 weeks after surgery, and the abdominal cavity was opened to observe the adhesion.

[0058] Figure 1 The scanning electron microscope images of the Janus hydrogel prepared in Example 3 and the AL and AAL hydrogels prepared separately. Figure 1 It can be seen from the figure that PSBMA presents a loose porous structure, while N2P2 prepared in Example 3 presents a smooth and flat structure. From the JGP transition layer prepared in Example 3, it can be seen that the structure changes from a smooth and flat surface to a loose and porous surface, indicating that SBMA successfully enters the AL network.

[0059] Figure 2 dN after drying of AL prepared in Example 1-6 X P Y Swelling curve of Figure 2 It can be found that the dN X P Y All of them reached equilibrium in 5-6 days. Due to the lack of AAc-NHS, the swelling of d-N0P2 is much higher than that of patches with other concentrations, which is not conducive to long-term adhesion. The main reason for its large swelling is the lack of AAc-NHS, which not only reduces the network cohesion, but also weakens the hydrophobic property. In addition, the swelling rates of the four groups from d-N2P2 to d-N2P5 at equilibrium are all between 70% and 80%, which is conducive to long-term adhesion. As p(APMA-co-THMA) increases from 2% to 5%, the swelling rate at equilibrium does not decrease successively, which may be the result of the interaction between the hydrophilicity and cohesion of the hydroxyl group.

[0060] Figure 3 The equilibrium swelling ratio of the AL dried hydrogel prepared in Example 3 and the JGP prepared in Example 3. Figure 3 It can be seen that there is a significant difference in the swelling ratio between d-N2P2 and JGP. JGP has a lower swelling ratio, which contributes to long-lasting adhesion. The main reason for this phenomenon is that the structure of the double-layer network is more stable.

[0061] Figure 4 dN after drying of AL prepared in Example 1-6 X P YMaximum adhesion force diagram. Figure 4 We can see that the adhesion of d-N0P2 without NHS group is lower than that of d-N2P2, which is mainly because NHS can react with amino groups on tissues to form amide covalent bonds (10.1038 / s41586-019-1710-5). When the amount of NHS is constant, with the increase of p(APMA-co-THMA) content, the adhesion shows a trend of first increasing and then decreasing. The increase is mainly due to the increase in p(APMA-co-THMA) content, which leads to more hydrogen bonds formed between the patch and the tissue. There are two possible reasons for the decrease, namely 1. The increase of p(APMA-co-THMA) leads to an increase in cohesion (which can also be seen from the tensile test). 2. The increase of p(APMA-co-THMA) leads to the consumption of NHS, which is because the amino groups on p(APMA-co-THMA) can form amide bonds with NHS. 3. The increase of p(APMA-co-THMA) leads to self-polymerization.

[0062] Figure 5 This is a comparison of the maximum wet tissue adhesion of undried N2P2 and d-N2P2 prepared in Example 3. Figure 5 It can be seen that by comparing N2P2 (undried) and d-N2P2 (dried), the wet tissue adhesion performance of d-N2P2 is much higher than that of N2P2, which is because d-N2P2 can remove the hydration layer on the tissue surface. From the overlap shear test, it can be concluded that the wet tissue adhesion of d-N2P2 can reach about 30kPa, while N2P2 can only reach 10kPa, so the drying method is effective in removing surface moisture.

[0063] Figure 6 The CCK-8 data of the undried N2P2 prepared in Example 3 and the JGP prepared in Example 2 are shown in FIG. Figure 6 It can be seen that the results of the CCK-8 assay showed that JGP and N2P2 had no toxicity to cells in 1 to 3 days.

[0064] Figure 7 The hemolysis test data of the undried N2P2 prepared in Example 3 and the JGP prepared in Example 2 are shown in FIG. Figure 7 It can be seen that the blood compatibility of JGP and N2P2 was determined by in vitro hemolysis test. The results showed that JGP and N2P2 did not cause obvious hemolysis, and the hemolysis rate was <5%

[0065] Figure 8 The anti-peritoneal adhesion effect of the JGP prepared in Example 3. Figure 8In the experiment, the abdominal cavity was opened on day 0 and the cecum was exposed. The cecum was damaged by repeated friction, resulting in obvious bleeding spots in the cecum. The experimental groups were divided into a control group (no treatment) and a treatment group (JGP). On day 14, the abdominal cavity was opened, and it was observed that the control group had obvious adhesions, with fibrin connection between the cecum and the abdominal wall. In the treatment group, no adhesions were found.

[0066] Based on the above tests, it can be concluded that the preparation method of the present invention is simple, efficient and low-cost. For AL, it forms a firm adhesion on wet tissue through the synergistic effect of non-covalent and covalent bonds of NHS groups, and the "tridentate hydrogen bond" of APMA-co-THMA provides AL with a long-lasting and strong adhesion effect. ALL utilizes the hydrophilicity of zwitterions to achieve anti-biological adhesion properties. Therefore, the Janus hydrogel patch prepared by the present invention has appropriate biocompatibility and excellent adhesion and anti-adhesion effects. It has broad application prospects in the field of biomedical materials.

[0067] The above are only examples of the features of the present invention and do not constitute any limitation on the protection scope of the present invention. Any technical solution formed by equivalent exchange or equivalent replacement falls within the protection scope of the present invention.

Claims

1. A Janus hydrogel with durable wet tissue adhesion and anti-peritoneal adhesion, characterized in that: It consists of an adhesion layer AL and an anti-adhesion layer AAL; The adhesive layer AL is mainly obtained by polymerizing p(APMA-co-THMA), methacrylic anhydride gelatin, acrylic acid and acrylic acid N-hydroxysuccinimide ester; the p(APMA-co-THMA) is obtained by polymerizing N-[tris(hydroxymethyl)methyl]acrylamide and N-(3-aminopropyl)methacrylamide hydrochloride; The anti-adhesion layer AAL is obtained by cross-linking reaction after soaking one side of the adhesion layer AL in AAL prefabricated liquid; the AAL prefabricated liquid includes [2-(methacryloyloxy)ethyl]dimethyl-(3-sulfonic acid propyl)ammonium hydroxide, methacrylic anhydride gelatin and N,N'-methylenebisacrylamide.

2. The Janus hydrogel with durable wet tissue adhesion and anti-peritoneal adhesion according to claim 1, characterized in that: The method comprises the following preparation steps: 1) Grafting methacrylic anhydride onto gelatin to obtain methacrylic anhydride gelatin, and polymerizing N-[tris(hydroxymethyl)methyl]acrylamide and N-(3-aminopropyl)methacrylamide hydrochloride to obtain p(APMA-co-THMA); 2) Preparing the AL pre-liquid for the adhesion layer: adding p(APMA-co-THMA), methacrylic anhydride gelatin and photoinitiator LAP into water; after fully dissolving and stirring at 40°C, adding acrylic acid and acrylic acid N-hydroxysuccinimide ester and stirring to obtain the AL pre-liquid; 3) Deoxygenating the AL prefabricated liquid and injecting it into the mold to cross-link under ultraviolet light to obtain the adhesive layer AL; then washing and drying; 4) preparing an anti-adhesion layer AAL preformed solution: adding [2-(methacryloyloxy)ethyl]dimethyl-(3-sulfonic acid propyl) ammonium hydroxide, methacrylic anhydride gelatin, N,N'-methylenebisacrylamide and ammonium persulfate into water and mixing them evenly to obtain an AAL preformed solution; 5) Soaking one side of the dried adhesive layer AL in the AAL prefabricated liquid for a period of time and then taking it out, and then thermally cross-linking it at 60°C to obtain the Janus hydrogel.

3. The Janus hydrogel with durable wet tissue adhesion and anti-peritoneal adhesion according to claim 2, characterized in that: The mass percentage concentration of each component in the AL prefabricated solution is: acrylic acid 30%; acrylic acid N-hydroxysuccinimide ester 2%; p(APMA-co-THMA) 2%; methacrylic anhydride gelatin 0.2%; photoinitiator LAP 0.2%.

4. The Janus hydrogel with durable wet tissue adhesion and anti-peritoneal adhesion according to claim 3, characterized in that: The concentrations of the components of the AAL prefabricated liquid are: 20% [2-(methacryloyloxy)ethyl]dimethyl-(3-sulfonic acid propyl) ammonium hydroxide; 0.6% N,N'-methylenebisacrylamide; 2% methacrylic anhydride gelatin; and 1% thermal initiator ammonium persulfate.

5. The Janus hydrogel with durable wet tissue adhesion and anti-peritoneal adhesion according to claim 2, characterized in that: In step 3), deoxygenation is performed by filling with nitrogen for 10-20 minutes.

6. The Janus hydrogel with durable wet tissue adhesion and anti-peritoneal adhesion according to claim 2, characterized in that: In step 3), the wavelength of the ultraviolet light is 365 nm and the irradiation time is 20-30 min.

Citation Information

Cited By

  • Rapid asymmetric tissue sealing patch as well as preparation method and application thereof

    CN120501917A